Insider · CIK 0001922174
Matthew L Bloomfield
Files at PSBD (Palmer Square Capital BDC Inc.). First filing Jan 19, 2024, latest Mar 24, 2025.
In brief
Matthew L Bloomfield files SEC Form 4 as president at PSBD (Palmer Square Capital BDC Inc.). Since Jan 19, 2024, Matthew L Bloomfield has reported 5 open-market buys worth $1.7M and 0 open-market sells worth $0, the latest filed on Mar 24, 2025.
After Matthew L Bloomfield's past buys, the stock trailed the S&P 500 by a median 19.0% over six months (n = 3), and 0% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $11k of PSBD on Mar 21, 2025, filed Mar 24, 2025, scored 25 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PSBD: Palmer Square Capital BDC Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | PSBDbuy Palmer Square Capital BDC Inc. | $11k 750 shares | +1% | - | |
| 44Moderate | PSBDbuy Palmer Square Capital BDC Inc. | $266k 17,450 shares | +42% | - | |
| 38Weak | PSBDbuy Palmer Square Capital BDC Inc. | $203k 13,200 shares | +47% | - | |
| 46Moderate | PSBDbuy Palmer Square Capital BDC Inc. | $247k 15,000 shares | +17% | +2% from low-3% from high | |
| 63Notable | Palmer Square Capital BDC Inc. | $1000k 60,790 shares | +241% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +750 | $14.51 | $11k | 59,678 | Mar 24, 2025 |
| Mar 7, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +5,200 | $15.43 | $80k | 46,678 | Mar 11, 2025 |
| Mar 10, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +5,250 | $15.25 | $80k | 51,928 | Mar 11, 2025 |
| Mar 11, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +7,000 | $15.05 | $105k | 58,928 | Mar 11, 2025 |
| Mar 4, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +4,200 | $15.38 | $65k | 32,478 | Mar 6, 2025 |
| Mar 5, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +5,000 | $15.34 | $77k | 37,478 | Mar 6, 2025 |
| Mar 6, 2025 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +4,000 | $15.48 | $62k | 41,478 | Mar 6, 2025 |
| Mar 4, 2024 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stockindirect: By Matthew L. Bloomfield Irrevocable Trust | +15,000 | $16.44 | $247k | 100,968 | Mar 5, 2024 |
| Jan 17, 2024 | PSBD Palmer Square Capital BDC Inc. | POpen-market purchase Common Stock | +60,790 | $16.45 | $1000k | 85,968 | Jan 19, 2024 |
Questions about Matthew L Bloomfield
Answered from the filings on this page, as of the latest one.
Is Matthew L Bloomfield buying or selling?
Not in the last 12 months. Matthew L Bloomfield's latest open-market trade on SEC Form 4 was bought $11k of PSBD on Mar 21, 2025.
How did Matthew L Bloomfield's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 19.0% over six months across 3 past buys, with 0% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Matthew L Bloomfield file Form 4?
Matthew L Bloomfield has filed Form 4 at PSBD (Palmer Square Capital BDC Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.